FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080036 [Registered on: 07/02/2025] Trial Registered Prospectively
Last Modified On: 31/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Study the efficacy of Bhrihatdhatryadi kwath in Urinary Tract Infection 
Scientific Title of Study   A Single arm clinical study to assess efficacy of Bhrihatdhatryadi kwatha in pittaj mutrakriccha (Urinary tract infection)  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Srushti Pratap Jagdale 
Designation  PG Scholar 
Affiliation  Bharati Vidyapeeth (deemed to be university) 
Address  Bharati Vidyapeeth deemed to be University college of ayurved and Hospital Department of kayachikitsa OPD no .04 katraj -Dhankawadi Pune

Pune
MAHARASHTRA
411043
India 
Phone  9096504050  
Fax    
Email  srushtijagdale107@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Virendra Pawar 
Designation  Assistant Professor  
Affiliation  Bharati Vidyapeeth (deemed to be university) 
Address  Bharati Vidyapeeth deemed to be University college of ayurved and Hospital Department of kayachikitsa OPD no .04 katraj -Dhankawadi Pune

Pune
MAHARASHTRA
411043
India 
Phone  9096743333  
Fax    
Email  virendra.pawar@bharatividyapeeth.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Srushti Pratap Jagdale 
Designation  PG Scholar 
Affiliation  Bharati Vidyapeeth (deemed to be university) 
Address  Bharati Vidyapeeth deemed to be University college of ayurved and Hospital Department of kayachikitsa OPD no .04 katraj -Dhankawadi Pune

Pune
MAHARASHTRA
411043
India 
Phone  9096504050  
Fax    
Email  srushtijagdale107@gmail.com  
 
Source of Monetary or Material Support  
Bharati vidyapeeth deemed to be university college of ayurved and hospital Kartaj Pune 411043 Maharashtra India 
 
Primary Sponsor  
Name  Dr Srushti Jagdale 
Address  Bharati Vidyapeeth (deemed to be university) college ofAyurved and Hospital Katraj Dhankawadi Campus Pune 411043 Maharashtra India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Srushti Jagdale  Bharati VidyapeethDeemed to beUniversity College ofAyurved and Hospital  Department of kayachikitsa ground floor opd no.4,second floor ipd Bharati vidyapeeth Ayurved hospital
Pune
MAHARASHTRA 
9096504050

srushti.jagdale-ayurved@bvp.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
BharatiVidyapeethDeemedtobeUniversityPuneIndiaCollegeofAyurvedpunesatararoad411043ETHICSCOMMITTEE[BVDUCOA EC]  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N390||Urinary tract infection, site notspecified. Ayurveda Condition: MUTRAKRUCCRAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Brihatdhatryadi kwath , Reference: Bhaishajya ratnavali 34/24, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -NIL
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. Subjects having classical sign and symptoms of Pittaj Mutrakriccha that is Hematuria, Painful micturition,Burning micturition,Difficulty during micturition,Increased frequency,Turbid urine.
2. Subjects of Pittaj Mutrakriccha of age group 18 years to 70 years.
3. Subjects with body temperature ranging from 99 oF to 104oF with Urinary Tract Infection. But if fever is more than 100 oF anti-pyretic will be added with Brihatdhatryadi Kwath.
4. Patients willing for trial and the patients who had no serious organic or metabolic ailments.
 
 
ExclusionCriteria 
Details  1. Pregnant and Lactating Women
2. Subject suffering from comorbid conditions like Uncontrolled HTN.
3. Case of associated obstructed uropathy and suffering from chronic illness like CKD.
4. Subject more than 104 oF body temperature.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Reduction of pus cells and body temperature to normal range

 
7 days

 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in sign and symptoms of Pittaj Mutrakriccha according to Charak Samhita approximately.

 
7 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   15/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study will conducted after obtaining permission from institutional ethical comittee and will be registar CTRI as per inclusion criteria patient will be selected.Subjective and Objective parameter will be checked.
whole research procedure and aim will be clearly inform to patients hence form will be signed by enrolled participants and case report form will be filled.
 
Close